JPS5844675B2 - コウセイブツシツカゴウブツノ セイホウ - Google Patents

コウセイブツシツカゴウブツノ セイホウ

Info

Publication number
JPS5844675B2
JPS5844675B2 JP49147519A JP14751974A JPS5844675B2 JP S5844675 B2 JPS5844675 B2 JP S5844675B2 JP 49147519 A JP49147519 A JP 49147519A JP 14751974 A JP14751974 A JP 14751974A JP S5844675 B2 JPS5844675 B2 JP S5844675B2
Authority
JP
Japan
Prior art keywords
acid
compound
group
protecting group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49147519A
Other languages
English (en)
Japanese (ja)
Other versions
JPS50105689A (fi
Inventor
イアン グレゴリー ゴードン
ブラツドシヨー ジヤニス
デイレツク コツカー ジヨン
ロナルド サザランド デイレツク
クリストフアー クツク マーチン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB59517/73A external-priority patent/GB1496757A/en
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of JPS50105689A publication Critical patent/JPS50105689A/ja
Publication of JPS5844675B2 publication Critical patent/JPS5844675B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP49147519A 1973-12-21 1974-12-20 コウセイブツシツカゴウブツノ セイホウ Expired JPS5844675B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB59517/73A GB1496757A (en) 1973-12-21 1973-12-21 Cephalosporin derivatives
GB4300574 1974-10-03

Publications (2)

Publication Number Publication Date
JPS50105689A JPS50105689A (fi) 1975-08-20
JPS5844675B2 true JPS5844675B2 (ja) 1983-10-04

Family

ID=26265028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49147519A Expired JPS5844675B2 (ja) 1973-12-21 1974-12-20 コウセイブツシツカゴウブツノ セイホウ

Country Status (15)

Country Link
JP (1) JPS5844675B2 (fi)
AT (1) AT344888B (fi)
CH (1) CH617703A5 (fi)
DE (1) DE2460537C2 (fi)
DK (1) DK674674A (fi)
ES (2) ES433226A1 (fi)
FI (1) FI65258C (fi)
FR (1) FR2255076B1 (fi)
HU (1) HU172234B (fi)
IE (1) IE42144B1 (fi)
IL (1) IL46302A (fi)
LU (1) LU71550A1 (fi)
NL (1) NL7416665A (fi)
NO (1) NO744621L (fi)
SE (1) SE7416195L (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144392A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
US4144393A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited 3-Acetoxymethyl cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyiminoarylacetamido group
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
US4165430A (en) 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4304770A (en) 1976-04-12 1981-12-08 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
GB1591439A (en) 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
GB1596278A (en) 1976-11-30 1981-08-26 Glaxo Operations Ltd 7-(-oxyimino-acetamino)cephalosporin derivatives
PH17188A (en) 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
DE2943427A1 (de) * 1978-10-27 1980-05-08 Glaxo Group Ltd Cephalosporinverbindungen
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2552432B2 (fr) * 1983-09-27 1985-10-25 Roussel Uclaf Nouvelles oximes derivees de l'acide 2-amino thiazol- 4-yl acetique, procede de preparation
US20040166434A1 (en) 2003-02-21 2004-08-26 Dammel Ralph R. Photoresist composition for deep ultraviolet lithography

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
GB1348984A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Antibiotics and processes for their production
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds

Also Published As

Publication number Publication date
NO744621L (fi) 1975-07-21
IE42144B1 (en) 1980-06-18
FI65258B (fi) 1983-12-30
DE2460537C2 (de) 1987-01-22
NL7416665A (nl) 1975-06-24
AT344888B (de) 1978-08-10
FI65258C (fi) 1984-04-10
IE42144L (en) 1975-06-21
FI371374A (fi) 1975-06-22
ATA1020174A (de) 1977-12-15
ES451604A1 (es) 1977-12-16
IL46302A (en) 1978-09-29
AU7673574A (en) 1976-06-24
CH617703A5 (en) 1980-06-13
HU172234B (hu) 1978-07-28
IL46302A0 (en) 1975-03-13
LU71550A1 (fi) 1976-04-13
JPS50105689A (fi) 1975-08-20
FR2255076A1 (fi) 1975-07-18
DE2460537A1 (de) 1975-07-03
DK674674A (fi) 1975-09-08
ES433226A1 (es) 1977-07-01
FR2255076B1 (fi) 1978-11-10
SE7416195L (sv) 1975-09-22

Similar Documents

Publication Publication Date Title
US4264595A (en) 7-[2-(2-Imino-4-thiazolin-4-yl)-2-(syn)-hydroxy-iminoacetamido]-cephalosporins
FI67705B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara (6,7r)-7-((z)-2-(2-aminotiazol-4-yl)-2-(substituerad oxiimi noacetamido)-(eventuellt substituerat pyridiniummetyl)cef-3 -e-4-karboxylatfoereningar
JPS5844675B2 (ja) コウセイブツシツカゴウブツノ セイホウ
US4144393A (en) 3-Acetoxymethyl cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyiminoarylacetamido group
JPS6354689B2 (fi)
US5017569A (en) Cephalosporin derivatives
FI56843C (fi) Foerfarande foer framstaellning av antibakteriella 7-(alfa-amino-p-hydroxifenylacetamido)-3-heterocykliska tiometylcefalosporiner
US4388316A (en) Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins
US4144392A (en) Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
KR830001130B1 (ko) 세팔로스포린 항생제의 제조방법
US4060686A (en) Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group
US4162360A (en) 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives
US4560683A (en) Cephalosporin antibiotics
JPS62209082A (ja) セフアロスポリン誘導体
US4687769A (en) 3-(3,3,3-trifluoropropenyl) cephalosporins
BE880037A (fr) Cephalosporines a activite antibiotique et procede de preparation
GB1604724A (en) 7-(2-aminothiazol-4-yl)-2-oxymino-acedamido)-cephem derivatives
US3985740A (en) 7-[D-(α-amino-α-phenyl-, 2-thienyl- and 3-thienylacetamido)]-3-(5-methylthiazol-2-yl)carbonylthiomethyl-3-cephem-4-carboxylic acids
US4761409A (en) Cephem derivatives
US4705784A (en) Cephem compounds
CA1067068A (en) 3-CARBAMOYLOXYMETHYL-7-(.alpha.-(1-CARBOXYCYCLOBUT-1-OXYIMINO)-.alpha.-(FUR-2-YL) ACETAMIDO) CEPH-3-EM-4-CARBOXYLIC ACID
SE438859B (sv) 7-acylamido-3-karbamoyloximetyl-3-cefem-4-karboxylsyraderivat och forfarande for framstellning derav
JPS63284183A (ja) 化合物
GB1602725A (en) 7-(a-oxyiminoacetamido)-ceph-3-em-4-carboxylic acid derivatives
US4963542A (en) Cephalosporin derivatives